Background:
Parkinson’s disease, PD
Coinvestigators listed in the Supplementary Material.Apomorphine sublingual film (SL-APO) and subcutaneous apomorphine (SC-APO) have been used for the treatment of OFF episodes in Parkinson’s disease (PD). No study has prospectively compared efficacy and safety of these formulations.